Skip to content
PubMed This is a summary of 35 peer-reviewed journal articles Updated
Medical Genetics

Mandibuloacral Dysplasia: A Patient Guide

At a Glance

Mandibuloacral dysplasia is a rare genetic condition that changes the jaw, collarbones, fingertips, skin, and body fat. Genetic testing identifies the subtype and helps guide monitoring of metabolism, heart valves, bones, blood pressure, and kidney function.

Mandibuloacral Dysplasia (MAD) is an exceptionally rare genetic condition that belongs to a family of disorders known as laminopathies. These are sometimes referred to as premature-aging syndromes because they affect the structural integrity of your body’s cells, causing certain tissues—particularly the skeleton, skin, and fat—to change in ways usually seen much later in life [1][2]. This term does not mean that every organ will age rapidly or that your lifespan is automatically shortened. While the diagnosis can feel overwhelming, understanding that MAD is a multisystem condition is the first step toward building a proactive care plan.

The condition is primarily defined by how it shapes the body’s framework. It commonly affects the development of the lower jaw (mandible) and the collarbones (clavicles), and it may cause the bones at the tips of the fingers to gradually thin, a process called acro-osteolysis [3][2]. Beyond these skeletal changes, MAD often involves lipodystrophy, which is a specialized term for the loss of the fatty tissue layer under the skin. This change in fat distribution is more than cosmetic; it fundamentally alters how your body processes energy, which is why long-term health management focuses heavily on your metabolic and internal organ health [2][4].

Researchers categorize MAD into different subtypes based on the specific gene involved. Type A (MADA) is linked to the LMNA gene and often features fat loss predominantly in the arms and legs, while Type B (MADB) is linked to the ZMPSTE24 gene and can involve more generalized fat loss and earlier skin changes [5][2]. A third, more recently identified form called MADaM affects the mitochondria—the “power plants” of your cells—and may involve more significant challenges with blood pressure and kidney function [6][7]. Identifying your specific subtype through specialized genetic testing is essential because it helps your medical team predict which systems, such as your heart valves or kidneys, require the closest monitoring [8].

Because MAD affects so many different parts of the body, the most effective way to manage it is through a multidisciplinary care team. This team usually includes specialists in genetics, endocrinology, cardiology, and orthopedics who work together to tailor your health monitoring [8]. Family planning options should also be discussed with a genetic counselor, as reproductive options depend on the gene and variant. While the skeletal and skin changes are the most visible parts of the condition, your long-term well-being is often driven by “silent” factors like heart valve health and insulin levels. By staying consistent with routine screenings and working with experts who understand the unique biology of laminopathies, you can navigate the challenges of this rare diagnosis and focus on maintaining an active, fulfilling life [2][4].

Common questions in this guide

What is mandibuloacral dysplasia?
Mandibuloacral dysplasia is a very rare genetic disorder that affects the jaw, collarbones, fingertips, skin, and the layer of fat under the skin. It can also change how the body handles energy and may require monitoring of the heart, kidneys, and metabolism.
What are the different types of mandibuloacral dysplasia?
Type A, also called MADA, is linked to changes in the LMNA gene and often causes fat loss in the arms and legs. Type B, or MADB, is linked to ZMPSTE24 and may involve more widespread fat loss and earlier skin changes. MADaM is a form involving the mitochondria and may be associated with greater blood pressure and kidney concerns.
How is mandibuloacral dysplasia diagnosed?
Diagnosis uses the person's physical findings together with specialized genetic testing. Testing can identify the gene or variant involved and help the care team determine which organs need the closest monitoring.
What health checks are important for someone with mandibuloacral dysplasia?
A care team may recommend baseline and ongoing checks of the heart valves, bone density, kidney function, blood pressure, and metabolic health. Insulin and triglyceride levels may also need closer monitoring because lipodystrophy can affect how the body processes energy.
Which specialists treat mandibuloacral dysplasia?
Care commonly involves medical genetics, endocrinology, cardiology, and orthopedics. A genetic counselor can also discuss family planning and reproductive options, which depend on the specific gene and variant.
Does the premature-aging label mean that mandibuloacral dysplasia always shortens lifespan?
No. The term describes changes in certain tissues that can resemble changes usually seen later in life; it does not mean that every organ ages rapidly or that lifespan is automatically shortened. Individual health risks depend in part on the subtype and the organs affected.

Get notified when new evidence is published on Mandibuloacral dysplasia.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (8)
  1. 1

    Mandibuloacral dysplasia: A premature ageing disease with aspects of physiological ageing.

    Cenni V, D'Apice MR, Garagnani P, et al.

    Ageing research reviews 2018; (42()):1-13 doi:10.1016/j.arr.2017.12.001.

    PMID: 29208544
  2. 2

    Mandibuloacral dysplasia type B (MADB): a cohort of eight patients from Suriname with a homozygous founder mutation in ZMPSTE24 (FACE1), clinical diagnostic criteria and management guidelines.

    Hitzert MM, van der Crabben SN, Baldewsingh G, et al.

    Orphanet journal of rare diseases 2019; (14(1)):294 doi:10.1186/s13023-019-1269-0.

    PMID: 31856865
  3. 3

    Mandibuloacral dysplasia and LMNA A529V mutation in Turkish patients with severe skeletal changes and absent breast development.

    Ozer L, Unsal E, Aktuna S, et al.

    Clinical dysmorphology 2016; (25(3)):91-7 doi:10.1097/MCD.0000000000000132.

    PMID: 27100822
  4. 4

    The Diagnosis and Management of Lipodystrophy Syndromes: A Multi-Society Practice Guideline.

    Brown RJ, Araujo-Vilar D, Cheung PT, et al.

    The Journal of clinical endocrinology and metabolism 2016; (101(12)):4500-4511 doi:10.1210/jc.2016-2466.

    PMID: 27710244
  5. 5

    Two Decades after Mandibuloacral Dysplasia Discovery: Additional Cases and Comprehensive View of Disease Characteristics.

    Jéru I, Nabil A, El-Makkawy G, et al.

    Genes 2021; (12(10)) doi:10.3390/genes12101508.

    PMID: 34680903
  6. 6

    Loss of MTX2 causes mandibuloacral dysplasia and links mitochondrial dysfunction to altered nuclear morphology.

    Elouej S, Harhouri K, Le Mao M, et al.

    Nature communications 2020; (11(1)):4589 doi:10.1038/s41467-020-18146-9.

    PMID: 32917887
  7. 7

    Case report: A novel splice-site mutation of MTX2 gene caused mandibuloacral dysplasia progeroid syndrome: the first report from China and literature review.

    Fu X, Chen S, Huang X, et al.

    Frontiers in endocrinology 2024; (15()):1345067 doi:10.3389/fendo.2024.1345067.

    PMID: 38544690
  8. 8

    Mutations Involved in Premature-Ageing Syndromes.

    Coppedè F

    The application of clinical genetics 2021; (14()):279-295 doi:10.2147/TACG.S273525.

    PMID: 34103969

This page explains mandibuloacral dysplasia and its monitoring needs for informational purposes only; it does not constitute medical advice. Discuss genetic testing, screening, and treatment decisions with a qualified care team familiar with rare disorders.